{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:30:19Z","timestamp":1776468619984,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.tcm.2017.10.002","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T16:46:28Z","timestamp":1508517988000},"page":"223-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non-PCI\/CABG therapies for refractory angina"],"prefix":"10.1016","volume":"28","author":[{"given":"Ki E.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Richard","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2017.10.002_bib1","first-page":"220","article-title":"Treatment of refractory angina","volume":"9","author":"Grise","year":"2009","journal-title":"Ochsner J"},{"key":"10.1016\/j.tcm.2017.10.002_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCINTERVENTIONS.112.000064","article-title":"Residual ischemia after revascularization in multivessel coronary artery disease: insights from measurement of absolute myocardial blood flow using magnetic resonance imaging compared with angiographic assessment","volume":"6","author":"Arnold","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2017.10.002_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"issue":"Suppl. G","key":"10.1016\/j.tcm.2017.10.002_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/eurheartj\/17.suppl_G.48","article-title":"The pathophysiology of myocardial ischaemia","volume":"17","author":"Detry","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2017.10.002_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.tcm.2017.10.002_bib6","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2017.10.002_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jacc.2010.12.052","article-title":"Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris","volume":"58","author":"Rajendra","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.10.002_bib8","first-page":"353","article-title":"Update on ranolazine in the management of angina","volume":"10","author":"Codolosa","year":"2014","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.tcm.2017.10.002_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2017.10.002_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/2047487312450133","article-title":"Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.","volume":"19","author":"Sendon","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tcm.2017.10.002_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.10.002_bib12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2017.10.002_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7861\/clinmedicine.13-1-63","article-title":"Pharmacological treatment of chronic stable angina pectoris","volume":"13","author":"Tarkin","year":"2013","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.tcm.2017.10.002_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10557-016-6681-2","article-title":"Management of stable angina\u2014current guidelines: a critical appraisal","volume":"30","author":"Thadani","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.tcm.2017.10.002_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003614.pub2","article-title":"Trimetazidine for stable angina","author":"Ciapponi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tcm.2017.10.002_bib16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2017.10.002_bib17","doi-asserted-by":"crossref","first-page":"e0151822","DOI":"10.1371\/journal.pone.0151822","article-title":"Does Enhanced External Counterpulsation (EECP) significantly affect myocardial perfusion?: a systematic review & meta-analysis","volume":"11","author":"Qin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2017.10.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane Systematic Review and Meta-Analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.10.002_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jchf.2016.12.019","article-title":"A novel rehabilitation intervention for older patients with acute decompensated heart failure: the REHAB-HF Pilot Study","volume":"5","author":"Reeves","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.tcm.2017.10.002_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/clc.4960240803","article-title":"Spinal cord stimulation for chronic intractable angina pectoris: a unified theory on its mechanism","volume":"24","author":"Latif","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2017.10.002_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ner.12349","article-title":"The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL Study): a pilot randomized controlled trial","volume":"19","author":"Eldabe","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.tcm.2017.10.002_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/VHRM.S8222","article-title":"Effectiveness of percutaneous laser revascularization therapy for refractory angina","volume":"6","author":"McGillion","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.tcm.2017.10.002_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13019-017-0602-8","article-title":"Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging","volume":"12","author":"Iwanski","year":"2017","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.tcm.2017.10.002_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis","volume":"118","author":"Khan","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2017.10.002_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/CRD.0000000000000101","article-title":"Narrowing of the coronary sinus: a device-based therapy for persistent angina pectoris","volume":"24","author":"Konigstein","year":"2016","journal-title":"Cardiol Rev"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173817301639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173817301639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T22:44:28Z","timestamp":1719528268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173817301639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1050173817301639"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2017.10.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-PCI\/CABG therapies for refractory angina","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}